Chargement en cours...

Lichenoid drug eruption due to imatinib mesylate

Imatinib mesylate is a selective tyrosinase kinase inhibitor which has revolutionized the treatment of chronic myeloid leukemia. It is also used in gastrointestinal stromal tumors and dermatofibrosarcoma protruberans. Cutaneous adverse reactions are the most common nonhematological side effects seco...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Int J Appl Basic Med Res
Auteurs principaux: Bhatia, Anuradha, Kanish, Bimal, Chaudhary, Paulina
Format: Artigo
Langue:Inglês
Publié: Medknow Publications & Media Pvt Ltd 2015
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4318107/
https://ncbi.nlm.nih.gov/pubmed/25664274
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2229-516X.149253
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!